|
Post by dreamboatcruise on Jan 26, 2016 11:54:45 GMT -5
If you are in at $11 or $5 I would say you are in trouble. I am in at 83 cents and 66 cents. If it gets over a $1 or even back to its $1.50 $2.00 range I am happy! Not sure what the next few months will hold. I will tell you 1 of the Vanguard funds has about 5 million shares of this stock or at least they did 2 months ago. Respecting board rules, I say this as kindly as might be possible... hold still, I want to beat you with a stick Though, in fairness if this goes bankrupt you will have lost 100% having bought with and average below $1 just the same as me having bought with average of $4.5. Still rather be you than me in this circumstance.
|
|
|
Post by kbrion77 on Jan 26, 2016 12:05:31 GMT -5
But Afrezza hasnt picked up cos of social media cos only people who understand Afrezza knows its benefits and most of the people are dumb too with no motivation It's a start. Keep in mind, people that were using social media for Affrezza aren't always experts with grass roots movements (sure, some of them are, but not all). That said, a concentrated effort could lead to other things- not a guarantee, mind you. But we now have a mysterious new partner- do you think SNY got that for us? Only time will tell- but I don't think we are sunk yet. Just my opinion. I bought more when we were around .67 or so. GLTA Our backs are against the wall no more than ever. I keep trying to find positives about the Sanofi termination but I'm still extremely concerned about it. The optimist in me says that Sanofi realized that due to Afrezza's incredible benefits the partnership just wasn't worth the 65% and cost associated with it to cannibalize Lantus/Toujeo/Apidra revenues. The pessimist in me says that Sanofi (who are still very smart people) realized something significantly wrong with Afrezza and that the barriers it faces will never be overcome (and if SNY couldn't break barriers how the hell can MNKD). This whole investing experience has just been bizarre in every single way. I truly think 10-15 years from now (here's to hoping MNKD has 6 products licensed out and generating significant annual revenues at that time) there will be articles/business cases about MNKD and how various media outlets impacted not only the share price but the company itself.
|
|
|
Post by dreamboatcruise on Jan 26, 2016 12:07:33 GMT -5
When we discover that this magical, invisible partner for our Technosphere platform has deep pockets, the share price will shoot back over $1. Time- before April. Then, dtc ads start for Afrezza, and we are off to the races. I don't follow that logic. There is no reason to suspect that there is any support for MNKD beyond what they've announced. I doubt that adding certainty to the viability of milestone payments would cause such optimism as the issue is still how far out they are. And everyone knows that no matter how deep pocketed investors are, drug development is never a sure thing. Sounds like this deal involves transfer of manufacturing technology, so RLS seems to have built in the protections in case of the demise of MNKD. I just don't see where the investors in RLS matter that much... I am discounting that people are really buying into the FUD that RLS is total shame concocted by MNKD, which if widely believed would result in positive if the belief were dispelled. Unless of course they turn out to really be magical.
|
|
|
Post by dreamboatcruise on Jan 26, 2016 12:22:01 GMT -5
This might be slightly off topic, but to help put things in perspective- Social Media has gotten world leaders elected. The old guard always underestimates it. As far as the stock price goes- if you believe in it- buy it. There will still be volatile until, at the VERY MINIMUM, April. No one, including your self, can be faulted for not buying more. If you aren't sure, wait a bit- the stock is going to be down for a bit. To help bring things back into perspective of reality. Politics is a HUGE topic on social media and especially where bad/corrupt leadership is oppressing people. People's A1c readings are NOT a topic of social media except for a very small slice of PWD's that are really engaged in optimizing their treatment. Further, MNKD itself is still restricted in what they can say on social media. For instance FDA requires "balance" in any marketing including a tweet. You have very limited space in a tweet and if you mention a positive you must also mention the adverse... is that a tweet that will go viral "#Afrezza, inhaled insulin, may cause hypos and cough, talk to your physician". The original tweet would go out from MNKD... the only people following MNKD would be us investors. Some of us may retweet, many of us don't even do tweeting, and the spread would probably end right there. For all the lameness of SNY they did do one thing that seemed like it could have generated some "social media buzz". They were basically bribing people to generate social media posts regarding afrezza by donating $5 to a diabetes foundation when they did so. And even that didn't result in any meaningful posts. I'm looking forward to some explanation of how social media will help them, but it sure isn't very straightforward.
|
|
|
Post by cjc04 on Jan 26, 2016 13:27:09 GMT -5
This might be slightly off topic, but to help put things in perspective- Social Media has gotten world leaders elected. The old guard always underestimates it. As far as the stock price goes- if you believe in it- buy it. There will still be volatile until, at the VERY MINIMUM, April. No one, including your self, can be faulted for not buying more. If you aren't sure, wait a bit- the stock is going to be down for a bit. To help bring things back into perspective of reality. Politics is a HUGE topic on social media and especially where bad/corrupt leadership is oppressing people. People's A1c readings are NOT a topic of social media except for a very small slice of PWD's that are really engaged in optimizing their treatment. Further, MNKD itself is still restricted in what they can say on social media. For instance FDA requires "balance" in any marketing including a tweet. You have very limited space in a tweet and if you mention a positive you must also mention the adverse... is that a tweet that will go viral "#Afrezza, inhaled insulin, may cause hypos and cough, talk to your physician". The original tweet would go out from MNKD... the only people following MNKD would be us investors. Some of us may retweet, many of us don't even do tweeting, and the spread would probably end right there. For all the lameness of SNY they did do one thing that seemed like it could have generated some "social media buzz". They were basically bribing people to generate social media posts regarding afrezza by donating $5 to a diabetes foundation when they did so. And even that didn't result in any meaningful posts. I'm looking forward to some explanation of how social media will help them, but it sure isn't very straightforward. I agree DBC, and your points regarding social media go along with my original theory on the failure of the MNKD/SNY deal. Al was convinced, and convinced SNY, that Afrezza would sell itself via the diabetic community, word of mouth, social media etc.... All singing the praises of Afrezza without being accountable to talk about the label. IMO, it's why the deal was set up as it was. If Afrezza were to take off, end of story, 25% royalty and mfg costs paid, we're rich. It's my worst case reason for why the deal ended. 1. SNY really was sandbagging Afrezza 2. The SNY story isn't over. Pick a reason, but my most realistic idea on this is that dosing and timing are a concern and CGM's / real time bs levels are needed (I'm experiencing this with my wife) so all parties are stepping back, in which case the current agreement doesn't work anyway. 3. SNY really did try, with the label they had to work with, and it just didn't work. Major resistance from docs & endos, major resistance from ins co's, and no organic demand to get the ball rolling. My wife is doing great! Better control than she's ever had, and that's without a CGM. I do believe a CGM is needed though, she's having to test 6 & 8 times a day because trying to match the quick peak of Afrezza with the peak of the sugar in what she's eating. Most importantly though, she sleeps very well now with no fear of a hypo. I hope something gets figured out to keep Afrezza alive!
|
|